Work

In Vitro Combination Therapy with Tegobuvir (GS-9190) is Highly Efficient in Curing Cells from HCV Replicon and in Delaying/Preventing the Development of Antiviral Resistance

Year: 2011

Type: article

Source: Antiviral Research

DOI: 10.1016/j.antiviral.2011.03.131

Authors: Inge Vliegen, Jan Paeshuyse, I-hung Shih, Gerhard Pürstinger, Steven Bondy, William A. Lee, Weidong Zhong, Johan Neyts

Institutions: Rega Institute for Medical Research, Gilead Sciences (United States), Universität Innsbruck

Language: English

Topic: Hepatitis C virus research

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2043731616

FWCI: 0.203

Cites:

Cited by: 1

Related to: 10